Pharmaceutical Published Insights

Published Date : 02 Apr, 2026

Global diabetic kidney disease market is estimated to be valued at USD 3.35 Bn in 2026 and is expected to exhibit a CAGR of 5.2% during the forecast period (2026 - 2033). Diabetic kidney disease (DKD) is a condition in which the kidneys are damaged due to long-stand... View more

Published Date : 02 Apr, 2026

Global cold laser therapy market is estimated to be valued at USD 129.8 Mn in 2026, and is expected to exhibit a CAGR of 4.9% during the forecast period (2026 - 2033). Cold laser therapy, also known as low-level laser therapy (LLLT), is a form of light therapy that ... View more

Published Date : 02 Apr, 2026

The global hormonal drugs market is estimated to be valued at USD 75 Bn in 2026 and is expected to reach USD 102 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 4.49% from 2026 to 2033. The global hormo... View more

Published Date : 02 Apr, 2026

The Global Erythromelalgia Treatment Market is estimated to be valued at USD 2.67 Billion in 2026 and is expected to reach USD 3.73 Billion by 2033, exhibiting a compound annual growth rate (CAGR) of 5.7% from 2026 to 2033. Erythromelalgia is a rare disease characteri... View more

Published Date : 02 Apr, 2026

The Global Acupuncture Market is estimated to be valued at USD 51.66 Bn in 2026 and is expected to reach USD 79.28 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 7.4% from 2026 to 2033. The global acupuncture market ha... View more

Published Date : 02 Apr, 2026

The Global Biosimilar Contract Manufacturing Market is estimated to be valued at USD 14.44 Bn in 2026 and is expected to reach USD 35.74 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 16.3% from 2026 to 2033. Biosimilars are biological products des... View more

Published Date : 02 Apr, 2026

The global life attenuated vaccines market size is estimated to be valued at USD 32.95 Bn in 2026 and is expected to expand at a CAGR of 11.7% from 2026 to 2033. Life attenuated vaccines use weakened or attenuated live microorganisms or pathogens to t... View more

Published Date : 02 Apr, 2026

The global concussion market is estimated to be valued at USD 7.70 Bn in 2026 and is expected to reach USD 11.10 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 6.3% from 2026 to 2033. The global concussion market is expected to witness significant ... View more

Published Date : 02 Apr, 2026

Bleeding Disorders Treatment Market Size and Forecast – 2026 – 2033 The Global Bleeding Disorders Treatment Market size is estimated to be valued at USD 12.3 billion in 2026 and is expected to reach USD 22.1 billion by 2033, exhibiting a compound annual growth rate (CAGR) of 8.6% from 2026 to 2... View more

Published Date : 02 Apr, 2026

The Global Autologous Cell Therapy Market is estimated to be valued at USD 6.74 Bn in 2026 and is expected to reach USD 22.55 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 22.3% from 2026 to 2033. The global autologou... View more

Published Date : 02 Apr, 2026

Glioblastoma multiforme or GBM is an aggressive and the most common form of brain cancer that involves glial cells. Gliomas are rapidly developing tumors that develop from the star-shaped glial cells present in the spinal cord or brain. Recurrent glioblastoma multifor... View more

Published Date : 02 Apr, 2026

The global multi dose drug vial adapters market is estimated to be valued at US$ 1,268.9 Mn in 2026 and is expected to exhibit a CAGR of 7.3% during the forecast period (2026 - 2033). Multi dose drug vial adapters are devices that allow the safe administration of me... View more

Published Date : 02 Apr, 2026

The global dyspareunia treatment market is estimated to be valued at USD 829.9 Mn in 2026 and is expected to exhibit a CAGR of 5.0% during the forecast period (2026 - 2033). Dyspareunia, or painful sexual intercourse, is a prevalent issue that affects women globally... View more

Published Date : 02 Apr, 2026

The global photobiomodulation market is estimated to be valued a USD 281.3 Mn in 2026 and is expected to reach USD 514.8 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 10.6% from 2026 to 2033.Photobiomodulation or low-level light therapy is a treat... View more

Published Date : 02 Apr, 2026

Antidepressants are medications prescribed to treat major depressive disorders. They are used to alter brain chemistry in order to relieve symptoms such as sadness, loss of interest, feelings of guilt or low self-worth, disturbed sleep or appetite, fatigue, and poor c... View more

Published Date : 02 Apr, 2026

Pegfilgrastim is a long-acting form of filgrastim that stimulates the bone marrow to produce more white blood cells. Pegfilgrastim biosimilars are follow-on biologics or subsequent entry biologics of pegfilgrastim. These biosimilars have no clinically meaningful differences in terms of safety, pu... View more

Published Date : 02 Apr, 2026

Nanotechnology-based drug delivery address many challenges in pharmaceutical research and development. By facilitating targeted and controlled delivery of therapeutic agents, nanotechnology improves  the solubility, stability and bioavailability of drug payloads.... View more

Published Date : 02 Apr, 2026

The global whole exome sequencing market is estimated to be valued at USD 2.38 Bn in 2026 and is expected to reach USD 5.57 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 15.2% from 2026 to 2033. Whole exome sequencing is a powerful technology that... View more